Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other forms of coccidioidomycosis
Summary
Other forms of coccidioidomycosis represent a category of fungal infections caused by Coccidioides species that do not fall into the acute pulmonary, chronic pulmonary, or meningitis classifications. These infections may involve extrapulmonary sites (e.g., skin, bones, joints) or present with atypical clinical features. The condition can range from localized disease to disseminated infection, with severity influenced by host immune status.
Causes
The infection results from inhaling airborne spores of Coccidioides fungi, which are endemic to arid regions such as the southwestern United States, Mexico, and parts of Central and South America. These spores are released from soil and become airborne during activities that disturb the ground, including construction, farming, or windstorms. Inhalation leads to infection, with potential spread to other organs in susceptible individuals.
Risk Factors
- Residence or travel to endemic regions, especially during dry, dusty seasons.
- Occupational exposure to soil (e.g., farmers, construction workers, archaeologists).
- Immunocompromised states, including HIV/AIDS, organ transplantation, or prolonged corticosteroid use.
- Pregnancy, particularly the third trimester.
- Advanced age.
Symptoms
- Fatigue and malaise.
- Cough, chest pain, or shortness of breath (if pulmonary involvement is present).
- Fever, night sweats, or weight loss.
- Joint pain, skin lesions, or bone pain (if extrapulmonary sites are affected).
- Severe cases may involve organ-specific symptoms (e.g., meningitis, skin nodules, or osteomyelitis).
Diagnosis
Diagnosis involves clinical evaluation, imaging (e.g., chest X-ray, CT, or MRI for extrapulmonary sites), and laboratory testing. Serologic tests (e.g., coccidioides antibody or antigen detection) and fungal cultures (from sputum, tissue, or body fluids) confirm infection. Biopsy may be required for extrapulmonary or atypical presentations to identify fungal elements.
Treatment Options
Treatment depends on disease severity and site of infection. Mild cases may resolve without therapy, while moderate to severe infections require antifungal medications (e.g., fluconazole, itraconazole). Disseminated or severe disease may necessitate intravenous therapy (e.g., amphotericin B) and prolonged treatment. Immunosuppressed patients often need extended therapy to prevent relapse.
Prognosis and Follow-Up
Prognosis varies by disease form and host factors. Mild infections typically have a good outcome with treatment, while disseminated or severe disease carries higher morbidity. Follow-up includes monitoring for symptom resolution, repeat imaging, and serologic testing to assess treatment response. Immunocompromised patients require long-term surveillance for recurrence.
Complications
- Disseminated infection affecting skin, bones, joints, or other organs.
- Chronic pulmonary disease with scarring or respiratory impairment.
- Meningitis or central nervous system involvement.
- Treatment-related toxicity (e.g., liver or kidney effects from antifungals).
Lifestyle & Prevention
- Avoid exposure to dust in endemic areas (e.g., wear masks during soil-disturbing activities).
- Stay indoors during dust storms or high-wind conditions.
- Promptly treat underlying immunocompromising conditions.
- Follow prescribed antifungal therapy and complete the full course.
When to Seek Professional Help
Seek care if symptoms worsen (e.g., persistent fever, severe cough, or new organ-specific pain) or if you have risk factors (e.g., immunocompromise) and suspect exposure. Immediate evaluation is needed for signs of severe disease (e.g., meningitis, respiratory distress) or treatment failure.
Tips for Medical Coders
Code B38.8 is assigned for coccidioidomycosis forms not classified elsewhere (e.g., extrapulmonary sites without pulmonary or meningitis involvement). Documentation should specify the site or atypical presentation to support coding. Ensure differentiation from acute/chronic pulmonary or meningitis codes, and verify no more specific subcategory applies.
B38.8 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.